⌘K
Loading ticker…
ALX Oncology Holdings Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, ALX Oncology Holdings Inc. Common Stock (ALXO) has a 3-month relative strength percentile of 40 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 75. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.7%, relative volume 11.16×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
40 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ALXO is in a stage 2 uptrend, week 1. Currently in a 88-day base; basing ADR 8.3% (broad 10.1%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 15.1% / 20.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ALXO is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $7M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $7M |
| VXFVanguard Extended Market ETF | 0.00% | $803K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALXO Jan avg: 5.18% median: -7.90% win: 25% σ: 33.07% n: 4 2022-04-12 → 2026-05-29 | ALXO Feb avg: -7.60% median: -11.43% win: 50% σ: 23.54% n: 4 2022-04-12 → 2026-05-29 | ALXO Mar avg: -26.01% median: -27.86% win: 0% σ: 16.13% n: 4 2022-04-12 → 2026-05-29 | ALXO Apr avg: 6.33% median: -13.32% win: 40% σ: 33.68% n: 5 2022-04-12 → 2026-05-29 | ALXO May avg: -12.71% median: -10.09% win: 40% σ: 25.45% n: 5 2022-04-12 → 2026-05-29 | ALXO Jun avg: -9.93% median: -4.51% win: 50% σ: 25.02% n: 4 2022-04-12 → 2026-05-29 (current) | ALXO Jul avg: 4.33% median: 0.51% win: 50% σ: 28.42% n: 4 2022-04-12 → 2026-05-29 | ALXO Aug avg: 14.63% median: 2.01% win: 50% σ: 71.13% n: 4 2022-04-12 → 2026-05-29 | ALXO Sep avg: 5.29% median: -4.44% win: 50% σ: 38.26% n: 4 2022-04-12 → 2026-05-29 | ALXO Oct avg: 9.89% median: 5.50% win: 50% σ: 34.35% n: 4 2022-04-12 → 2026-05-29 | ALXO Nov avg: -1.80% median: -2.54% win: 50% σ: 9.55% n: 4 2022-04-12 → 2026-05-29 | ALXO Dec avg: 21.69% median: 7.18% win: 75% σ: 47.18% n: 4 2022-04-12 → 2026-05-29 |